Statistics
Publications
20
Citations
1.5K
H-Index
17
Active since
1997
David M. Irlbeck is an author at GlaxoSmithKline (United States) specializing in molecular virology, antiretroviral therapy, and virology.
Publications per year
1997–2022
20
20
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
Christopher C. Nixon, Maud Mavigner, Gavin C. Sampey et al. · Nature · 2020 · 319 citations · Full text
Ian J. Caley, Michael R. Betts, David M. Irlbeck et al. · Journal of Virology · 1997 · 123 citations · Full text
1–5 of 20